Skip to main content
✦Prime Rate:7.00%✦Fed Funds:3.88%✦5 Yr Treasury:4.95%↓✦10 Yr Treasury:5.10%↓✦30 Yr Treasury:5.43%↓✦30 Yr Mortgage:7.11%·Updated Nov 12, 2026✦Prime Rate:7.00%✦Fed Funds:3.88%✦5 Yr Treasury:4.95%↓✦10 Yr Treasury:5.10%↓✦30 Yr Treasury:5.43%↓✦30 Yr Mortgage:7.11%·Updated Nov 12, 2026
Rates
Hydralive

Hydralive

The total investment to open a Hydralive franchise ranges from $257,150 to $496,400. The initial franchise fee is $49,500. Ongoing royalties are 7% plus a 1% advertising fee.

What is the Hydralive franchise?

Hydralive Therapy operates in the health and wellness sector, providing intravenous, or IV, hydration therapy, vitamin injections, and other wellness services in a modern, spa like setting. The company was founded in 2016 and began offering franchise opportunities as early as 2019, although other sources state that franchising began in 2022. Its corporate roots are in Homewood, AL, with an official office at 3500 Independence Drive, Suite 200, Homewood, AL 35259. Another source identifies Birmingham, AL, as its headquarters. President and CEO Brandon Stewart leads the privately held, venture capital backed company. Hydralive completed a $2.2 million seed funding round on June 5, 2024. The 2025 Franchise Disclosure Document reports 4 total units, including 1 franchised owned location and 3 company owned locations. Other reports identify 6 units since 2016, including 2 US franchises. Current locations are concentrated in the southeastern United States, with locations in Alabama and Georgia. The franchise gives buyers an entry into a market focused on preventative and restorative health services and growing consumer demand.

Hydralive operates in a growing IV hydration therapy market. The global market was valued at USD 2.71 billion to USD 2.74 billion in 2024 and is projected to reach USD 7.44 billion by 2035, representing a 9.5% compound annual growth rate from 2025 to 2035. North America held a 47% share of the market in 2024. The US market was valued at USD 1.11 billion in 2024 and is expected to reach USD 2.43 billion by 2034, with an 8.15% compound annual growth rate from 2025 to 2034. Demand is supported by greater health awareness and increased interest in preventive care, trends that accelerated as wellness priorities changed after the pandemic. Busy professionals, athletes, and travelers use elective drips for energy, immune support, and recovery. Consumers are also seeking immediate wellness services and individualized IV drips. Mobile and at home IV services are growing at a 12.8% compound annual growth rate, while corporate wellness programs are adding IV therapy as an employee benefit. NAD+ drips are among the faster growing infusion types, with a projected 15.2% compound annual growth rate through 2030. The broader healthcare services market is projected to grow by USD 7,589.9 billion at a 9.1% compound annual growth rate from 2025 to 2030, with North America contributing 40.6% of that expansion. The market remains fragmented while moving toward greater consolidation, giving Hydralive room to develop its regional presence.

The initial franchise fee for a Hydralive Therapy location is $49,500. Estimated total initial investment ranges from $257,150 to $496,400. Other sources report ranges of $257,000 to $496,000 or $245,150 to $417,150, with differences tied to leasehold improvements, geography, and the required build out. The investment includes the $49,500 franchise fee, leasehold improvements estimated at $10,000 to $180,000, and one month of rent and a security deposit totaling $4,000 to $9,000. Clinic supplies are estimated at $19,200 to $25,000, while equipment is listed at $101,900. Insurance costs range from $2,000 to $3,500. Computer systems, security cameras, and telephones cost $2,000 to $5,000. Signage costs $4,000 to $15,000. Utility deposits and business licenses range from $350 to $3,000. Legal and accounting fees can reach $2,500. Opening advertising is estimated at $10,000 to $20,000, architect fees at $9,200 to $12,000, and clinic furniture at $30,000 to $40,000. Franchisees are advised to set aside $15,000 to $30,000 in additional funds for the first three months of working capital. Applicants must show a net worth of $250,000. The company’s privately held, venture capital backed structure and its $2.2 million seed round on June 5, 2024, are additional facts for buyers reviewing the corporate background.

A typical Hydralive clinic generally needs one Registered Nurse and one front desk employee per shift. Licensed registered nurses administer IV therapies and vitamin injections, with oversight from a board certified physician. Before treatment, each client has a brief virtual consultation with a medical professional to confirm an appropriate wellness plan. The front desk coordinator greets clients, manages scheduling and bookings, handles check ins and check outs, answers questions, processes transactions, and keeps the clinic organized. Wellness Nurses administer IV therapies and vitamin injections, educate clients, monitor sessions for safety and effectiveness, maintain medical records, and assist with general clinic duties. Hydralive supplies training and ongoing guidance. Its corporate support team and Medical Directors provide updates on local medical requirements and HIPAA compliance. Franchisees are connected with a board certified Medical Director who supervises clinical operations and helps obtain required licenses, including medical licenses and Drug Enforcement Administration, or DEA, licenses needed to order pharmaceuticals and other medical supplies. Support includes weekly meetings during the first six months after opening, a field visit at six months, and biweekly meetings from six months through one year. Owners may work directly in daily operations or focus more on marketing and building a local customer base. Franchisee comments describe the business as becoming less time consuming after opening and once the operating process is established, which may support income diversification. Hydralive also offers a degree of territory protection. After approving a location, the franchisor defines an area where it agrees not to place another franchisee, subject to compliance with the franchise agreement. Clinics generally require 1,250 to 2,000 square feet.

That figure should be considered alongside the global IV hydration therapy market, which was valued at USD 2.71 billion to USD 2.74 billion in 2024 and is projected to reach USD 7.44 billion by 2035 at a 9.5% compound annual growth rate. One franchise in Columbus, GA, reportedly reached positive cash flow within six months of opening. The company completed a $2.2 million growth equity raise on June 5, 2024, led by private investors. The brand has a Moderate Loan Activity Score of 50. Hydralive added Weight Loss Therapy using GLP 1 injections and Hormone Replacement Therapy, or HRT, beginning September 1, 2024. These services add revenue options alongside the existing model.

Hydralive’s growth information varies by source. PeerSense’s direct database lists 2 total franchised units, while the 2025 Franchise Disclosure Document reports 4 total units, consisting of 1 franchised owned location and 3 company owned locations. Other sources report 6 units since 2016, including 2 US franchises. The company’s current expansion is focused mainly on the southeastern United States, with locations in Alabama and Georgia. Hydralive completed a $2.2 million growth equity raise on June 5, 2024, through a group of private investors. The company stated that the capital would support an aggressive franchise growth strategy and the addition of medical services. On August 27, 2024, Hydralive announced Weight Loss Therapy with GLP 1 injections and HRT, which began on September 1, 2024. These offerings join IV therapy, vitamin injections, cryotherapy, and compression therapy. The brand’s points of differentiation include a spa like setting, a broad and expanding service menu, and access to board certified Medical Directors for clinical supervision and licensing assistance. Owners may take different levels of involvement in the business. The investment requirement and space requirement are both relatively limited within the figures provided, with clinics requiring 1,250 to 2,000 square feet. The franchisor also helps provide access to IV bag supplies and products, supporting consistency and day to day operations across locations. The model is intended to support reliable service, convenience, and personalized care.

A prospective Hydralive owner should have entrepreneurial motivation, interest in health and wellness, the ability to manage an investment of $257,150 to $496,400, and a required net worth of $250,000. The brand does not explicitly require prior industry experience or a specific management background. Existing franchisee accounts describe the value of having a structured plan in place, with the game plan already written out, which may suit experienced business owners and first time entrepreneurs. Owners can choose a hands on operating role or concentrate on marketing and local customer development. Once established, the business is described as capable of operating with limited owner oversight, making the model relevant to buyers seeking income diversification or a business that can be managed alongside other professional commitments. Hydralive Franchising LLC is expanding mainly across the southeastern United States, where current locations include Alabama and Georgia, while the franchise model is available across the entire U.S. Approved locations receive a defined surrounding territory in which the franchisor agrees not to place another franchisee, provided the owner follows the franchise agreement. Franchise partners in Columbus, GA, are planning a second location, showing the possibility of multi unit ownership and further development in an established market. The exact time from signing to opening is not stated. Training and continuing support, including weekly and biweekly meetings, are intended to guide owners through the launch process.

Hydralive Therapy is positioned in a health and wellness category with material consumer demand and a growing IV hydration therapy market. The global market was valued at USD 2.71 billion to USD 2.74 billion in 2024 and is projected to reach USD 7.44 billion by 2035 at a 9.5% compound annual growth rate. The investment range is $257,150 to $496,400, and the required net worth is $250,000. Hydralive’s $2.2 million growth equity raise on June 5, 2024, is intended to support expansion and new services. Weight Loss Therapy with GLP 1 injections and HRT began on September 1, 2024, adding to the brand’s existing wellness services and its potential revenue sources. A Columbus, GA, franchise reportedly reached positive cash flow within six months. PeerSense is a commercial capital advisory firm that introduces franchise buyers to SBA and conventional lenders. It does not lend, fund, or approve loans. Its franchise research includes SBA lending history, a Loan Activity Score, location maps with Google ratings, FDD financial data, and comparison tools.

Loan Activity Score

65/100

SBA Default Rate

0.0%

Active Lenders

3

According to its Franchise Disclosure Document or public business records, Hydralive has 2 locations, all owned by franchisees. Public SBA loan records show 3 lenders made 3 loans to franchisees of Hydralive. PeerSense calculates Hydralive's score as 65 out of 100, using public SBA loan performance and recent lending activity. Cost figures are based on the 2026 Franchise Disclosure Document. To correct a figure, email the current FDD and the differing item numbers to info@peersense.com, and this page will be updated.

Franchising since 2021 · 2 locations

Investment

$257,150 to $496,400

Franchise Fee

$49,500

Total Units

2

2 franchised

Loan Activity Score
Low
65
SBA Lending
25
Lender Quality
5
Transparency
14
Reach
4
Momentum
17

Proprietary PeerSense metric

Strong
Capital Sources
3SBA lenders

Distinct lenders in public SBA records for Hydralive

3

Total SBA loans

$475K

Average loan size

Source: public SBA 7(a) and 504 loan records through December 31, 2025

Referral fee at closing

SBA Lending Activity for Hydralive

Loan Activity Score Breakdown

Emerging (3 to 9 loans)

Limited Data
65out of 100
Strong
Market Momentum17/35

Are lenders increasingly or decreasingly funding this brand? Growing trends score highest.

Loan Safety25/25

Blended default rate (recent + all time) compared to NAICS sector peers.

Lender Confidence5/15

Quality lenders actively backing this brand, with penalty for lender pullback.

Transparency14/15

FDD availability, Item 19 disclosure, and overall data completeness.

Footprint4/10

Geographic spread of SBA funded locations across states.

SBA Lending Performance

SBA Default Rate

0.0%

vs 3.2% peer avg

SBA Loans

3

Total Volume

$1.4M

Active Lenders

3

States

3

vs. SBA Sector Average

+3.2%lower default rate

SBA loan default rate vs. all franchises in the same NAICS sector, not limited to direct competitors

Key Highlights

Low SBA default rate (0.0%)
Item 19 financial data disclosed

Data Insights

Key performance metrics for Hydralive based on SBA lending data

SBA Default Rate

0.0%

3.2% below peer avg

SBA Loan Volume

3 loans

Across 3 lenders

Lender Diversity

3 lenders

Avg 1.0 loans per lender

Investment Tier

Significant investment

$257,150 to $496,400 total

Hydralive: Deep SBA Data

Brand specific metrics derived directly from SBA 7(a) approval records: peak lending year, leading state, average loan size, and lender concentration. PeerSense computes these per brand so capital advisors and prospective franchisees can benchmark this opportunity against the rest of the franchise universe.

Peak SBA Year

2026

2 approvals. The best year on record for Hydralive.

Top SBA State

District of Columbia

1 SBA financed Hydralive locations, the densest operator footprint.

Average Loan Size

$475K

Median $468K. Use as a sizing anchor when modeling your own Hydralive unit.

Lender Concentration

100%

Concentrated

Share of Hydralive approvals captured by the top 3 SBA lenders.

Hydralive's SBA lending pipeline peaked in 2026 (2 approvals). The last five fiscal years account for 100% of cumulative volume ($1.4M approved). Operator density is highest in District of Columbia with 1 SBA financed locations. Average funded ticket sits at $475K, with the median at $468K. Lender mix is concentrated: the top three SBA lenders account for 100% of approvals. Credit decisions concentrate with a small group of incumbents.

Payment Estimator

Loan Amount$206K
Interest Rate9.5%
Term (Years)10 yr

Estimated Monthly Payment

$2,662

Principal & Interest only

Indicative only, as of November 1, 2026. Not a quote, commitment or offer of credit. Final pricing, leverage and terms are determined by the lender at underwriting, after full transaction materials are reviewed. PeerSense sources the file. The lender sets pricing. What these terms mean.

Locations

Hydralive, unit breakdown

Total Units
N/A
Franchisee Owned
n/a
System Owned
n/a
Closed
n/a

Explore Funding for Hydralive

Our business financing consultants help connect you with the right lending partners. Referral fee paid at closing.

Optional: checking the consent box lets us call or text you about your funding. You can still submit without it.

Referral fee at closing

Or get an instant analysis

Scan Your Deal Instantly

4 FDDs Available for Hydralive

Review franchise fees, investment ranges, royalties, Item 19 financial data, and year over year trends. Request complimentary access through your PeerSense funding advisor.

Hydralive

Page Review

Reviewed by Edward L. Freeman, Founder and Managing Director, PeerSense

  • PeerSense is a capital advisory firm that places commercial financing with direct capital sources; the capital source sets final terms.
  • Edward L. Freeman founded PeerSense in January 2020.
  • He is a Registered Franchise Consultant with Business Alliance, Inc., a credential issued in March 2022, and worked as a franchise consultant there from March 2022 to May 2023.
  • His recorded experience includes a $22 million SBA construction loan, with about $16 million funded on the deal.
  • In the 12 months through September 30, 2026, PeerSense tracked 912 publicly announced financings with a disclosed size of $361.32 billion. PeerSense Capital Data Report · Methodology page

Last reviewed LinkedIn profileAbout Edward Freeman

This is not a franchise offering and does not constitute financial, investment, or legal advice. Data is sourced from Franchise Disclosure Documents (FDDs), public filings, and third party sources and may contain inaccuracies. The figures reflect the FDD on file for the year shown and may have been superseded or extracted with errors. PeerSense is not a financial advisor, attorney, or accountant. Always consult the brand's current FDD and seek professional guidance from a qualified attorney, accountant, or financial advisor before making any franchise investment decision. See full Terms & Conditions.